GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
94 hedge funds and large institutions have $863M invested in G1 Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 93 → 94 (+1)
Holders
94
Holding in Top 10
1
Calls
$401K
Puts
$245K
Top Buyers
| 1 | +$20.6M | |
| 2 | +$16.7M | |
| 3 | +$16.3M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$9.66M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$8.97M |
Top Sellers
| 1 | -$30M | |
| 2 | -$10.5M | |
| 3 | -$7.83M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5.29M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.15M |